James Lorens
JL
James Lorens
Professor at University of Bergen
About
James Lorens is an academic entrepreneur with over 35 years of research and industry experience in cancer biology and immunology. He is a Professor at the Department of Biomedicine, University of Bergen, and a founding scientist of BerGenBio ASA, a clinical-stage biopharmaceutical company. Lorens's work focuses on the AXL receptor tyrosine kinase and its role in tumor progression, metastasis, and drug resistance.
Frequently asked
Who is James Lorens?
James Lorens is an academic entrepreneur with over 35 years of research and industry experience in cancer biology and immunology. He is a Professor at the Department of Biomedicine, University of Bergen, and a founding scientist of BerGenBio ASA, a clinical-stage biopharmaceutical company. Lorens's work focuses on the AXL receptor tyrosine kinase and its role in tumor progression, metastasis, and…
What is James Lorens's current role?
James Lorens is currently Professor at University of Bergen.
Comments
No comments yet. Be the first to share your take.
Profile
About James Lorens
James Lorens is Professor at University of Bergen. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.